Japan Novartis Unit Set To Resume Smoking-Cessation Drug Supplies
This article was originally published in PharmAsia News
Executive Summary
Novartis Pharma KK of Japan says it is set to resume normal shipment amounts of its anti-smoking drug as the market begins to catch up with demand